Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications

Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2.

Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2.

Journal: RMD open
Published: January 02, 2024

Concept and understanding of non-radiographic axial spondyloarthritis

Concept and understanding of non-radiographic axial spondyloarthritis

Journal: Zhonghua yi xue za zhi
Published: November 20, 2023

Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA).

Upadacitinib for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA).

Journal: Expert review of clinical immunology
Published: November 13, 2023

Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study.

Comparison of the ASAS Health Index in patients classified as radiographic axial spondyloarthritis (axSpA) or non-radiographic axSpA in the ASAS Health Index international validation study.

Journal: RMD open
Published: October 06, 2023

Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials.

Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials.

Journal: Arthritis research & therapy
Published: September 25, 2023

Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis.

Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis.

Journal: Clinical and translational science
Published: September 08, 2023

Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices.

Radiographic and non-radiographic axial spondyloarthritis are not routinely distinguished in everyday clinical care: an analysis of real-world data from rheumatology practices.

Journal: Rheumatology international
Published: August 07, 2023

Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies.

Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies.

Journal: Annals of the rheumatic diseases
Published: August 01, 2023

A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis.

A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis.

Journal: Autoimmunity reviews
Published: July 15, 2023

Advances in pharmacotherapies for axial spondyloarthritis.

Advances in pharmacotherapies for axial spondyloarthritis.

Journal: Expert opinion on pharmacotherapy
Published: June 15, 2023

Patients' Perspectives on Axial Pain in Relation to Inflammation and Structural Damage in a Large Cohort of Axial Spondyloarthritis Patients.

Patients' Perspectives on Axial Pain in Relation to Inflammation and Structural Damage in a Large Cohort of Axial Spondyloarthritis Patients.

Journal: Arthritis care & research
Published: June 05, 2023

Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation.

Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation.

Journal: Frontiers in endocrinology
Published: May 22, 2023
Showing 1-12 of 57

Last Updated: 10/31/2025